Navigation Links
Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes
Date:6/27/2011

es occur and continues long after it is diagnosed, often until no insulin production remains. During the early months after diabetes is diagnosed, most people still have some functioning beta cells. These cells, with the help of insulin injections, make it easier to control blood glucose. If this period can be extended, researchers hope that more people will be able to achieve better control of their blood glucose.  In some cases, intervention may be possible before clinical diabetes develops.

TrialNet researchers are conducting a series of studies to test ways to prevent or delay progression of type 1 diabetes. At this week's ADA meeting, TrialNet researchers will announce two ongoing studies aimed at preventing or delaying type 1 diabetes in people at high risk for the disease: relatives of people who already have it. One trial is testing an experimental drug called teplizumab, another immune system modulator; the other study is testing oral insulin, which may induce tolerance, or a quieting of the immune responses that lead to type 1 diabetes.  Several other TrialNet reports will be presented that expand our understanding of how type 1 diabetes develops.

Type 1 diabetes appears to involve both genetic risk factors and less understood environmental factors that may interact to initiate the development of diabetes. To identify people at high risk for type 1 diabetes, TrialNet offers free screening for relatives of people with the disease. Screening involves a simple blood test for markers (autoantibodies) that often appear years before diabetes develops. Knowing the number and type of markers makes it possible to identify those at different risk levels for developing type 1 diabetes. Among people with a relative with type 1 diabetes, the chances of developing the disease are 15 times greater than for those with no family history. Screening can refine this risk estimate.

Nearly 200 U.S. TrialNet locations offer screening and conduct s
'/>"/>

SOURCE TrialNet
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years
2. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
3. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
4. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
5. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
6. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
7. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
10. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
11. New Studies Support CardioFocus HeartLight™ Endoscopic Ablation Systems Notable Treatment Results for Paroxysmal Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 /PRNewswire/ - Merus Labs International ... MSLI ) is pleased to announce today ... has exercised the over-allotment option to purchase 1,000,550 ... price of C$3.05 per Share granted to the ... public offering which closed on April 30, 2015.  ...
(Date:6/1/2015)... LAKE, N.J. , June 1, 2015 ... Ltd., today announces the immediate appointment of Ivor ... Chief Financial Officer (CFO) and Chief Compliance Officer. In ... responsibility for leading Eisai,s financial operations in the Americas ... audit functions. He will also serve on the company,s ...
(Date:6/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/whgw4t/breast_pumps ) has announced the ... Double Electric and Hospital Grade Breast Pumps) - Global ... 2014 - 2022" report to their offering. ... and Drug Administration. These pumps are designed to mimic ... act as a supplement to breastfeeding. The demand for ...
Breaking Medicine Technology:Merus Labs International Inc. Announces Closing of Exercise of Over-Allotment Option 2Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai Inc. 2Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai Inc. 3Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai Inc. 4Global Breast Pumps Market (Manual, Single, Double Electric and Hospital Grade Breast Pumps) - Industry Analysis 2015-2022 2
... BOSTON, Nov. 22, 2011 Solos Endoscopy, Inc.,s (OTCPK: ... 3rd Quarter with a Net Profit of $73,895.  Solos ... of debt of $299,082 for the Three Months period ... new consulting agreement result in a reduction of ongoing ...
... Mont., Nov. 22, 2011 Bacterin International Holdings, Inc. ... the development of revolutionary bone graft material and antimicrobial coatings ... MICRO,s 4th Annual Conference on December 8, 2011. The conference ... Bacterin,s chairman and CEO, Guy Cook, is scheduled ...
Cached Medicine Technology:Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2Bacterin to Present at 4th Annual LD MICRO Conference on December 8, 2011 2Bacterin to Present at 4th Annual LD MICRO Conference on December 8, 2011 3
(Date:6/1/2015)... Dallas, Texas (PRWEB) June 01, 2015 ... the brain health landscape on a global level. ... innovative realms, allowing Carrick Brain Centers to broaden their ... of healing. , Broadened horizons are accompanied by a ... June 1, 2015, Carrick Brain Centers will separate itself ...
(Date:6/1/2015)... 2015 The session, entitled “Building the ... vice president of Elektrobit Automotive Americas, senior representatives ... it will be moderated by Andy Gryc of CX3 ... and complexity of in-vehicle software in connected vehicles and ... and how the wider ecosystem can fit into new ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Good360 ... of the Irene W. and C.B. Pennington Foundation, ... organization’s board of directors. Bertman joins Good360 just ... platform this summer. , "Bringing with her many ... I am thrilled that Lori is joining the ...
(Date:6/1/2015)... Palo Alto, Calif. (PRWEB) June 01, 2015 ... weight loss program for children and teens, announced today ... support and coaching channels for kids and teens to eat ... Kurbo users communicated with their coaches via text message and ... advice, and supportive reminders through their in-app chat window. For ...
(Date:6/1/2015)... June 01, 2015 Community Scene ( ... the official launch of its free online platform designed ... 18,000 cities nationwide and globally. , On Community Scene, ... what’s happening in their community – including local news, ... voting polls. Members can choose a home community or ...
Breaking Medicine News(10 mins):Health News:Carrick Brain Centers announces separation from Dr. Frederick Carrick to reflect the broader scope of impact and growth as an organization. 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Kurbo, First Mobile Weight Loss Program for Children and Teens, Enhances Coaching with New iOS In-App Chat and Messaging from Coaches 2Health News:Community Scene Launches the Largest Global Social Network for Communities 2
... , WEDNESDAY, May 30 (HealthDay News) -- ... sold online, contains the wrong active ingredients, according to ... also used to treat narcolepsy. The drug, made by ... the United States. The counterfeit versions of Adderall ...
... May 30 (HealthDay News) -- More patients and families are ... if doing do improves the chances of obtaining a donor ... Medical Center in Maywood, Ill., examined 91 Facebook pages that ... and found that 12 percent of the pages reported receiving ...
... Reinberg HealthDay Reporter , WEDNESDAY, May 30 (HealthDay ... during birth and who received whole-body cooling fared better than ... Although rare, the condition can result in brain damage ... by temporarily lowering their body temperature seems to help the ...
... FORT KNOX, Ky., May 30, 2012 Last month, ... around the country attended the American College of Physicians, ... national medical student abstract competitions and share their perspective ... residents earned national awards for their research. "The ...
... 30 (HealthDay News) -- Advancements in human genetic ... are needed to protect against the misuse of people,s ... association offers several policy recommendations, including U.S. government oversight ... anti-discrimination legislation. While discoveries in recent years -- ...
... PHILADELPHIAYounger patients with colorectal cancer were more likely to present ... had better than or equal survival to patients 50 and ... Society of Clinical Oncology Annual Meeting in Chicago. (Abstract #3621, ... Hall A2). The study was led by Edith ...
Cached Medicine News:Health News:FDA Warns of Fake Version of ADHD Drug Adderall 2Health News:More Families Seek Kidney Donations on Facebook 2Health News:'Cooling' Helps Oxygen-Deprived Newborns: Study 2Health News:'Cooling' Helps Oxygen-Deprived Newborns: Study 3Health News:US Army internal medicine residents receive awards from American College of Physicians 2Health News:Brave New World of Genetics Requires Safeguards, Experts Say 2Health News:ASCO: Younger colon cancer patients have worse prognosis at diagnosis, yet better survival 2
... The IEC CL40 and FL40 ... power, safety and versatility to increase ... with a broad array of rotors ... processing and microplate applications, the IEC ...
... IEC CL30 Series from Thermo ... value for your low-speed clinical ... rotor exchange system, user-friendly controls, ... IEC CL30 Series delivers solid ...
Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1 / 2, HIV 1/ 2 STAT-PAK and HIV 1/ 2 STAT-PAK Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of anti...
... more supple gloving category than standard,latex gloves. ... thin,powder-free gloves on the market today1. Yet ... come to expect from natural rubber latex. ... comes with another huge,advantage it is ...
Medicine Products: